Better access to AYUSH services in India

Better access to AYUSH services in India

Government of India has approved and notified National AYUSH Mission (NAM) for better access to AYUSH services; strengthening of AYUSH educational institutions, facilitate the enforcement

Provenge – Sipuleucel-T may have added benefit in prostate cancer

Sipuleucel-T in prostate cancer: Indication of added benefit – Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.

Health Newstrack